RESEARCH-USE BIOSIMILAR ANTIBODY
Anumigilimab
Monoclonal antibody · IgG4
Anumigilimab (CSL-324) is an human IgG4 mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation.
TARGETCSF3R
YMonoclonal antibody
CATALOGSC-BS-766
CATALOG NUMBERSC-BS-766
MOLECULAR WEIGHTApprox. 143.86 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Anumigilimab (CSL-324) is an human IgG4 mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation.
Anumigilimab is a recombinant research-use antibody directed against CSF3R.